Related Experiment Video
Updated: Sep 14, 2025

Examining Changes in HRV and Emotion Following Artmaking with Three Different Art Materials
Published on: January 11, 2020
The impact of COVID-19 infection on ART outcomes: a multicenter retrospective cohort study
Ruiqi Wang1,2,3,4,5, Yaqi Lin1,2,3,4,5, Lixue Chen1,2,3,4,5
1Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, 100191, China.
Objective:
This multicenter retrospective study examines the impact of female COVID-19 infection on assisted reproductive technology (ART) outcomes, including clinical pregnancy rates, miscarriage rates, and live birth rates, and further evaluated potential influencing factors associated with these outcomes.
Methods:
Our multicenter retrospective cohort study analyzed 10,140 cycles (2021-2023) from 10 Beijing ART centers, comparing 4,099 cycles from COVID-19-positive women with 6,041 age-matched (1:1.5) COVID-negative controls (pre-pandemic). Outcomes included pregnancy, miscarriage, and live birth rates, analyzed via logistic regression.
Results:
In our study, maternal COVID-19 infection showed no significant association with ART outcomes, including clinical pregnancy, miscarriage and live birth. However, subtle differences were still observed. Among women with prior COVID-19 infection, compared to those with transfers ≥ 90 days post-infection (16.1%), miscarriage rates were significantly higher in the < 30 days (20.5%, p = 0.055) and 30-60 days (20.4%, p = 0.032) groups, whereas no increase was observed in the 60-90 days group (15.3%, p = 0.912). Additionally, advanced maternal age and elevated FSH levels (> 10 mIU/mL) were associated with diminished clinical pregnancy and live birth rates. What's more, maternal COVID-19 symptoms and medication use did not significantly affect ART treatment outcomes.
Conclusions:
Our results suggest that while maternal COVID-19 infection does not clearly affect overall ART outcomes, embryo transfer within 60 days may increase miscarriage risk. This provides useful guidance for timing treatment during COVID-19 and future public health emergencies.
In Brief:
Our study found that while a history of the female partner's COVID-19 infection does not significantly impact ART outcomes, miscarriage rates are higher when embryo transfer occurs within 60 days post-infection. We recommend waiting at least 60 days after infection to minimize miscarriage risk.
More Related Videos
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Bias in Epidemiological Studies
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Confounding in Epidemiological Studies
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Acute Coronary Syndrome III: Diagnostic Studies